Global Acetyl-L Carnitine (ALC) Market
Global Acetyl-L Carnitine (ALC) Market

Acetyl-L Carnitine (ALC) Comprehensive Study by Application (Healthcare, Pharmaceutical, Others), Form (Capsule, Tablets, Powder) Players and Region - Global Market Outlook to 2024

Acetyl-L Carnitine (ALC) Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Sep 2019 Edition 217 Pages 211 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Vendors landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Key Vendors of Acetyl-L Carnitine (ALC) Market Study:
Post Holdings (United States), GNC (United States), Nature's Way (United States), Nature's Bounty (United States), NOW foods (United States), Swanson (United States), MRM (United States), Myprotein (United States), Primaforce (United States) and Vitamin World (United States)

In the last few years, Global market of Acetyl-L Carnitine (ALC) developed rapidly. Major factors driving the market are Rising Health Consciousness among Consumers .

On the basis of applications, the Acetyl-L Carnitine (ALC) market is segmented by Healthcare, Pharmaceutical and Others.

Some of the other players that are also part of study are Teinlab (United States), NutraKey (United States) and Nutraceutical (United States). The Global Acetyl-L Carnitine (ALC) market is gaining huge competition due to involvement of United States companies that constantly invest in research & development to meet market expectation with new innovation.

Research Methodology:

The top-down and bottom-up approaches are used to estimate and validate the size of the Global Acetyl-L Carnitine (ALC) market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Acetyl-L Carnitine (ALC) market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers, Raw Material Suppliers, Distributors and Traders, Research Organisations, Government Agencies and Organisations.
This helps us to gather the data for the players’ revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Application
  • Healthcare
  • Pharmaceutical
  • Others
By Form
  • Capsule
  • Tablets
  • Powder

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Health Consciousness among Consumers
      • 3.2.2. Wide Application in Health Care Products
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness among the Consumers
    • 3.4. Market Trends
      • 3.4.1. Inclination of Consumers Towards
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Acetyl-L Carnitine (ALC), by Application, Form and Region (value and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Acetyl-L Carnitine (ALC) (Value)
      • 5.2.1. Global Acetyl-L Carnitine (ALC) by: Application (Value)
        • 5.2.1.1. Healthcare
        • 5.2.1.2. Pharmaceutical
        • 5.2.1.3. Others
      • 5.2.2. Global Acetyl-L Carnitine (ALC) by: Form (Value)
        • 5.2.2.1. Capsule
        • 5.2.2.2. Tablets
        • 5.2.2.3. Powder
      • 5.2.3. Global Acetyl-L Carnitine (ALC) Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Acetyl-L Carnitine (ALC) (Price)
  • 6. Acetyl-L Carnitine (ALC): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Post Holdings (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. GNC (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nature's Way (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Nature's Bounty (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. NOW foods (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Swanson (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MRM (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Myprotein (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Primaforce (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Vitamin World (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Acetyl-L Carnitine (ALC) Sale, by Application, Form and Region (value and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Acetyl-L Carnitine (ALC) (Value)
      • 7.2.1. Global Acetyl-L Carnitine (ALC) by: Application (Value)
        • 7.2.1.1. Healthcare
        • 7.2.1.2. Pharmaceutical
        • 7.2.1.3. Others
      • 7.2.2. Global Acetyl-L Carnitine (ALC) by: Form (Value)
        • 7.2.2.1. Capsule
        • 7.2.2.2. Tablets
        • 7.2.2.3. Powder
      • 7.2.3. Global Acetyl-L Carnitine (ALC) Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Acetyl-L Carnitine (ALC) (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Acetyl-L Carnitine (ALC): by Application(USD Million)
  • Table 2. Acetyl-L Carnitine (ALC) Healthcare , by Region USD Million (2013-2018)
  • Table 3. Acetyl-L Carnitine (ALC) Pharmaceutical , by Region USD Million (2013-2018)
  • Table 4. Acetyl-L Carnitine (ALC) Others , by Region USD Million (2013-2018)
  • Table 5. Acetyl-L Carnitine (ALC): by Form(USD Million)
  • Table 6. Acetyl-L Carnitine (ALC) Capsule , by Region USD Million (2013-2018)
  • Table 7. Acetyl-L Carnitine (ALC) Tablets , by Region USD Million (2013-2018)
  • Table 8. Acetyl-L Carnitine (ALC) Powder , by Region USD Million (2013-2018)
  • Table 9. South America Acetyl-L Carnitine (ALC), by Country USD Million (2013-2018)
  • Table 10. South America Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 11. South America Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 12. Brazil Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 13. Brazil Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 14. Argentina Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 15. Argentina Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 16. Rest of South America Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 17. Rest of South America Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 18. Asia Pacific Acetyl-L Carnitine (ALC), by Country USD Million (2013-2018)
  • Table 19. Asia Pacific Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 20. Asia Pacific Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 21. China Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 22. China Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 23. Japan Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 24. Japan Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 25. India Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 26. India Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 27. South Korea Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 28. South Korea Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 29. Taiwan Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 30. Taiwan Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 31. Australia Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 32. Australia Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 33. Rest of Asia-Pacific Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 34. Rest of Asia-Pacific Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 35. Europe Acetyl-L Carnitine (ALC), by Country USD Million (2013-2018)
  • Table 36. Europe Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 37. Europe Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 38. Germany Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 39. Germany Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 40. France Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 41. France Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 42. Italy Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 43. Italy Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 44. United Kingdom Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 45. United Kingdom Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 46. Netherlands Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 47. Netherlands Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 48. Rest of Europe Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 49. Rest of Europe Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 50. MEA Acetyl-L Carnitine (ALC), by Country USD Million (2013-2018)
  • Table 51. MEA Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 52. MEA Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 53. Middle East Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 54. Middle East Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 55. Africa Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 56. Africa Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 57. North America Acetyl-L Carnitine (ALC), by Country USD Million (2013-2018)
  • Table 58. North America Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 59. North America Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 60. United States Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 61. United States Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 62. Canada Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 63. Canada Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 64. Mexico Acetyl-L Carnitine (ALC), by Application USD Million (2013-2018)
  • Table 65. Mexico Acetyl-L Carnitine (ALC), by Form USD Million (2013-2018)
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Acetyl-L Carnitine (ALC): by Application(USD Million)
  • Table 77. Acetyl-L Carnitine (ALC) Healthcare , by Region USD Million (2019-2024)
  • Table 78. Acetyl-L Carnitine (ALC) Pharmaceutical , by Region USD Million (2019-2024)
  • Table 79. Acetyl-L Carnitine (ALC) Others , by Region USD Million (2019-2024)
  • Table 80. Acetyl-L Carnitine (ALC): by Form(USD Million)
  • Table 81. Acetyl-L Carnitine (ALC) Capsule , by Region USD Million (2019-2024)
  • Table 82. Acetyl-L Carnitine (ALC) Tablets , by Region USD Million (2019-2024)
  • Table 83. Acetyl-L Carnitine (ALC) Powder , by Region USD Million (2019-2024)
  • Table 84. South America Acetyl-L Carnitine (ALC), by Country USD Million (2019-2024)
  • Table 85. South America Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 86. South America Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 87. Brazil Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 88. Brazil Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 89. Argentina Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 90. Argentina Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 91. Rest of South America Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 92. Rest of South America Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 93. Asia Pacific Acetyl-L Carnitine (ALC), by Country USD Million (2019-2024)
  • Table 94. Asia Pacific Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 95. Asia Pacific Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 96. China Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 97. China Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 98. Japan Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 99. Japan Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 100. India Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 101. India Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 102. South Korea Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 103. South Korea Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 104. Taiwan Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 105. Taiwan Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 106. Australia Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 107. Australia Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 108. Rest of Asia-Pacific Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 109. Rest of Asia-Pacific Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 110. Europe Acetyl-L Carnitine (ALC), by Country USD Million (2019-2024)
  • Table 111. Europe Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 112. Europe Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 113. Germany Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 114. Germany Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 115. France Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 116. France Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 117. Italy Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 118. Italy Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 119. United Kingdom Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 120. United Kingdom Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 121. Netherlands Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 122. Netherlands Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 123. Rest of Europe Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 124. Rest of Europe Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 125. MEA Acetyl-L Carnitine (ALC), by Country USD Million (2019-2024)
  • Table 126. MEA Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 127. MEA Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 128. Middle East Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 129. Middle East Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 130. Africa Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 131. Africa Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 132. North America Acetyl-L Carnitine (ALC), by Country USD Million (2019-2024)
  • Table 133. North America Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 134. North America Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 135. United States Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 136. United States Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 137. Canada Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 138. Canada Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 139. Mexico Acetyl-L Carnitine (ALC), by Application USD Million (2019-2024)
  • Table 140. Mexico Acetyl-L Carnitine (ALC), by Form USD Million (2019-2024)
  • Table 141. Research Programs/Design for This Report
  • Table 142. Key Data Information from Secondary Sources
  • Table 143. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Acetyl-L Carnitine (ALC): by Application USD Million (2013-2018)
  • Figure 5. Global Acetyl-L Carnitine (ALC): by Form USD Million (2013-2018)
  • Figure 6. South America Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 7. Asia Pacific Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 8. Europe Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 9. MEA Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 10. North America Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 11. Global Acetyl-L Carnitine (ALC) share by Players 2018 (%)
  • Figure 12. Global Acetyl-L Carnitine (ALC) share by Players (Top 3) 2018(%)
  • Figure 13. Global Acetyl-L Carnitine (ALC) share by Players (Top 5) 2018(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Post Holdings (United States) Revenue, Net Income and Gross profit
  • Figure 16. Post Holdings (United States) Revenue: by Geography 2018
  • Figure 17. GNC (United States) Revenue, Net Income and Gross profit
  • Figure 18. GNC (United States) Revenue: by Geography 2018
  • Figure 19. Nature's Way (United States) Revenue, Net Income and Gross profit
  • Figure 20. Nature's Way (United States) Revenue: by Geography 2018
  • Figure 21. Nature's Bounty (United States) Revenue, Net Income and Gross profit
  • Figure 22. Nature's Bounty (United States) Revenue: by Geography 2018
  • Figure 23. NOW foods (United States) Revenue, Net Income and Gross profit
  • Figure 24. NOW foods (United States) Revenue: by Geography 2018
  • Figure 25. Swanson (United States) Revenue, Net Income and Gross profit
  • Figure 26. Swanson (United States) Revenue: by Geography 2018
  • Figure 27. MRM (United States) Revenue, Net Income and Gross profit
  • Figure 28. MRM (United States) Revenue: by Geography 2018
  • Figure 29. Myprotein (United States) Revenue, Net Income and Gross profit
  • Figure 30. Myprotein (United States) Revenue: by Geography 2018
  • Figure 31. Primaforce (United States) Revenue, Net Income and Gross profit
  • Figure 32. Primaforce (United States) Revenue: by Geography 2018
  • Figure 33. Vitamin World (United States) Revenue, Net Income and Gross profit
  • Figure 34. Vitamin World (United States) Revenue: by Geography 2018
  • Figure 35. Global Acetyl-L Carnitine (ALC): by Application USD Million (2019-2024)
  • Figure 36. Global Acetyl-L Carnitine (ALC): by Form USD Million (2019-2024)
  • Figure 37. South America Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 38. Asia Pacific Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 39. Europe Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 40. MEA Acetyl-L Carnitine (ALC) Share (%), by Country
  • Figure 41. North America Acetyl-L Carnitine (ALC) Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Post Holdings (United States)
  • GNC (United States)
  • Nature's Way (United States)
  • Nature's Bounty (United States)
  • NOW foods (United States)
  • Swanson (United States)
  • MRM (United States)
  • Myprotein (United States)
  • Primaforce (United States)
  • Vitamin World (United States)
Additional players considered in the study are as follows:
Teinlab (United States) , NutraKey (United States) , Nutraceutical (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation